Stocks to Watch Today: Among airline shares, SpiceJet has reported seven aircraft related incidents in the last two months; while IndiGo said has hired over 1,500 cabin crew staff to counter likely at
The high court, however, directed the jail superintendent to hand over the custody of associate vice president of Biocon Biologics L Praveen Kumar
15% turnover investment in research could make companies eligible for the scheme
The company has entered into an agreement for the purpose of "acquisition of solar power by acquiring equity stake up to 26 per cent in AREREPL", it said.
Stocks to watch today: Akash M Ambani will take over as non-executive director and chairman of the board of directors of Reliance Jio; Tata Motors will hike prices of CVs by 1.5 to 2.5 per cent.
CBI on Tuesday moved the Delhi High Court seeking the custody of officials accused of allegedly demanding bribes to waive the Phase-3 trial of "Insulin Aspart Injection"
The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2
Stocks to watch today: Adani Enterprises subsidiary raised over Rs 6,000 crore to set up greenfield copper refinery; State-run IOB will boost advances across retail, corporate and MSME loans this year
All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody
The company said its product approvals are backed by science and clinical data
The CBI registered a case of criminal conspiracy and corruption against Reddy, posted at CDSCO headquarters, and Dinesh Dua, Director at Synergy Network India Private Limited, among others.
In the past one year, the stock has slipped 22 per cent, as against a 39 per cent rally in the S&P BSE Sensex.
The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics. Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to the notice filed with the regulator. Covidshield Technologies Pvt Ltd (CTPL), a wholly-owned subsidiary of Serum Institute of Life Sciences, will be merged into Biocon Biologics. In a tweet on Wednesday, the watchdog said it has cleared the "merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15 per cent equity shareholding of Biocon Biologics by Serum Institute Life Sciences." CTPL was incorporated to undertake the business of marketing, selling and distributing vaccines, drugs and other pharmaceutical products. Biocon Biologics Ltd is a subsidiary of Biocon Ltd. It offers treatment for chronic and acute diseases such as
Stocks to Watch: The US markets suffered the biggest one-day sell-off in almost two years -Investors worry about inflation and its impact on earnings and prospects for monetary policy tightening
Biocon Biologics is a subsidiary of Biocon Ltd
The BJP used the signing of MoU for setting up the largest semiconductor fabrication unit in Karnataka to hit out at Shaw
Biocon's consolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period
As of 06:50 AM, the SGX Nifty April futures quoted at 17,066. According to analysts, the April series has been one of the most volatile series for the Nifty in recent times. The options data.
The BJP accused her of imposing personal and 'politically coloured' opinion and conflating it with India's leadership in Information technology and biotechnology sectors
Mazumdar-Shaw, who is also the Executive Chairperson of Biocon Biologics, will be joining RSE's current fellowship of around 1,700 fellows, the company said in a statement